• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intravenous Hydration and Contrast-Induced Acute Kidney Injury: Too Much of a Good Thing?

作者信息

Gupta Rajesh, Moza Ankush, Cooper Christopher J

机构信息

Cardiovascular Division, Department of Medicine, University of Toledo, OH

Cardiovascular Division, Department of Medicine, University of Toledo, OH.

出版信息

J Am Heart Assoc. 2016 May 27;5(6):e003777. doi: 10.1161/JAHA.116.003777.

DOI:10.1161/JAHA.116.003777
PMID:27233299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4937294/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ffe/4937294/b2b539f36089/JAH3-5-e003777-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ffe/4937294/b2b539f36089/JAH3-5-e003777-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ffe/4937294/b2b539f36089/JAH3-5-e003777-g001.jpg

相似文献

1
Intravenous Hydration and Contrast-Induced Acute Kidney Injury: Too Much of a Good Thing?静脉补液与造影剂诱导的急性肾损伤：好事过头了？
J Am Heart Assoc. 2016 May 27;5(6):e003777. doi: 10.1161/JAHA.116.003777.
2
20-Hour preprocedural hydration is not superior to 5-hour preprocedural hydration in the prevention of contrast-induced increases in serum creatinine and cystatin C.20 小时术前水化与 5 小时术前水化相比，在预防对比剂诱导的血清肌酐和胱抑素 C 升高方面并无优势。
Int J Cardiol. 2013 Sep 1;167(5):2200-3. doi: 10.1016/j.ijcard.2012.05.122. Epub 2012 Jun 19.
3
Post-Contrast Acute Kidney Injury and Intravenous Prophylactic Hydration: An Update.对比剂急性肾损伤与静脉预防性水化：更新。
Rofo. 2021 Feb;193(2):151-159. doi: 10.1055/a-1248-9178. Epub 2020 Dec 16.
4
Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.水化联合或不联合N-乙酰半胱氨酸对接受冠状动脉造影和经皮冠状动脉介入治疗患者造影剂肾病的影响。
Mymensingh Med J. 2011 Apr;20(2):264-9.
5
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.速尿联合等渗盐水水化预防对比剂肾病：MYTHOS 研究（对比剂肾病预防中渗透性利尿联合等渗盐水水化与标准水化的比较）
JACC Cardiovasc Interv. 2012 Jan;5(1):90-7. doi: 10.1016/j.jcin.2011.08.017.
6
In adults at risk for contrast-induced nephropathy, no prophylactic hydration was noninferior to hydration.在有发生对比剂肾病风险的成年人中，不进行预防性水化并不劣于进行水化。
Ann Intern Med. 2017 Jun 20;166(12):JC66. doi: 10.7326/ACPJC-2017-166-12-066.
7
[Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial].[预防水化以保护对比剂肾病高危患者的肾功能免受血管内碘化造影剂损害（AMACING）：一项前瞻性、随机、3期、对照、开放标签、非劣效性试验]
Ned Tijdschr Geneeskd. 2018;161:D1734.
8
Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients.中心静脉压指导下的液体管理对慢性肾脏病和充血性心力衰竭患者对比剂肾病的预防作用。
JACC Cardiovasc Interv. 2016 Jan 11;9(1):89-96. doi: 10.1016/j.jcin.2015.09.026. Epub 2015 Dec 9.
9
The place of hydration using intravenous fluid in patients at risk of developing contrast-associated nephropathy.在有发生对比剂肾病风险的患者中使用静脉补液进行水化治疗的位置。
Br J Hosp Med (Lond). 2020 Sep 2;81(9):1-7. doi: 10.12968/hmed.2020.0394. Epub 2020 Sep 5.
10
Comparison of Intravenous and Oral Hydration in the Prevention of Contrast-Induced Acute Kidney Injury in Low-Risk Patients: A Randomized Trial.低风险患者中静脉补液与口服补液预防对比剂所致急性肾损伤的比较：一项随机试验
Nephron. 2015;131(1):51-8. doi: 10.1159/000438907. Epub 2015 Aug 26.

引用本文的文献

1
Anisodamine for the prevention of contrast-induced nephropathy in patients with acute coronary syndrome: a pilot systematic review and meta-analysis of randomized controlled trials.山莨菪碱预防急性冠状动脉综合征患者造影剂肾病：一项随机对照试验的初步系统评价和荟萃分析
Ann Med Surg (Lond). 2024 May 21;86(7):4123-4129. doi: 10.1097/MS9.0000000000002181. eCollection 2024 Jul.
2
Incomplete Recovery from the Radiocontrast-Induced Dysregulated Cell Cycle, Adhesion, and Fibrogenesis in Renal Tubular Cells after Radiocontrast (Iohexol) Removal.造影剂去除后，肾管状细胞的辐射诱导失调细胞周期、黏附和纤维化未完全恢复（碘海醇）。
Int J Mol Sci. 2023 Jun 30;24(13):10945. doi: 10.3390/ijms241310945.
3

本文引用的文献

1
Excessively High Hydration Volume May Not Be Associated With Decreased Risk of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Patients With Renal Insufficiency.对于肾功能不全患者，经皮冠状动脉介入治疗后，过高的水化量可能与对比剂诱导的急性肾损伤风险降低无关。
J Am Heart Assoc. 2016 May 27;5(6):e003171. doi: 10.1161/JAHA.115.003171.
2
RenalGuard system in high-risk patients for contrast-induced acute kidney injury.用于对比剂诱导的急性肾损伤高危患者的RenalGuard系统。
Am Heart J. 2016 Mar;173:67-76. doi: 10.1016/j.ahj.2015.12.005. Epub 2015 Dec 17.
3
Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients.
Neutrophil gelatinase-associated lipocalin monitoring reveals persistent subclinical kidney injury following intraarterial administration of iodinated contrast agents.
中性粒细胞明胶酶相关脂质运载蛋白监测显示，动脉内给予碘造影剂后持续存在亚临床肾脏损伤。
Sci Rep. 2022 Nov 14;12(1):19464. doi: 10.1038/s41598-022-24169-7.
4
Forced Diuresis with Matched Isotonic Intravenous Hydration Prevents Renal Contrast Media Accumulation.等渗静脉补液配合强制利尿可预防肾脏造影剂蓄积。
J Clin Med. 2022 Feb 8;11(3):885. doi: 10.3390/jcm11030885.
5
Acute kidney injury following percutaneous mechanical thrombectomy of subclavian artery stent graft thrombosis: a case report.锁骨下动脉支架移植物血栓形成经皮机械血栓清除术后急性肾损伤：一例报告
CVIR Endovasc. 2020 Jun 1;3(1):27. doi: 10.1186/s42155-020-00119-0.
6
Use of Both Serum Cystatin C and Creatinine as Diagnostic Criteria for Contrast-Induced Acute Kidney Injury and Its Clinical Implications.血清胱抑素C和肌酐联合用作对比剂诱导的急性肾损伤的诊断标准及其临床意义
J Am Heart Assoc. 2017 Jan 13;6(1):e004747. doi: 10.1161/JAHA.116.004747.
中心静脉压指导下的液体管理对慢性肾脏病和充血性心力衰竭患者对比剂肾病的预防作用。
JACC Cardiovasc Interv. 2016 Jan 11;9(1):89-96. doi: 10.1016/j.jcin.2015.09.026. Epub 2015 Dec 9.
4
Randomized Trial of Bicarbonate or Saline Study for the Prevention of Contrast-Induced Nephropathy in Patients with CKD.碳酸氢盐或生理盐水预防慢性肾脏病患者造影剂肾病的随机试验
Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1519-24. doi: 10.2215/CJN.05370514. Epub 2015 Jul 16.
5
Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry.经皮冠状动脉介入治疗患者急性肾损伤的当代验证风险模型：来自国家心血管数据注册中心导管介入治疗注册库的见解
J Am Heart Assoc. 2014 Dec;3(6):e001380. doi: 10.1161/JAHA.114.001380.
6
Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial.血流动力学指导的液体管理预防对比剂急性肾损伤：POSEIDON 随机对照试验。
Lancet. 2014 May 24;383(9931):1814-23. doi: 10.1016/S0140-6736(14)60689-9.
7
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.速尿联合等渗盐水水化预防对比剂肾病：MYTHOS 研究（对比剂肾病预防中渗透性利尿联合等渗盐水水化与标准水化的比较）
JACC Cardiovasc Interv. 2012 Jan;5(1):90-7. doi: 10.1016/j.jcin.2011.08.017.
8
Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).乙酰半胱氨酸预防行冠状动脉和外周血管造影术患者的肾脏结局：来自随机乙酰半胱氨酸预防对比剂肾病试验（ACT）的主要结果。
Circulation. 2011 Sep 13;124(11):1250-9. doi: 10.1161/CIRCULATIONAHA.111.038943. Epub 2011 Aug 22.
9
Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions.基于肾功能的对比剂剂量调整，以确定接受经皮冠状动脉介入治疗的患者中造影剂的安全界限。
J Am Coll Cardiol. 2011 Aug 23;58(9):907-14. doi: 10.1016/j.jacc.2011.05.023.
10
Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury.对比剂管理后肾功能不全试验 II（REMEDIAL II）：肾保护系统在高危对比剂诱导急性肾损伤患者中的应用。
Circulation. 2011 Sep 13;124(11):1260-9. doi: 10.1161/CIRCULATIONAHA.111.030759. Epub 2011 Aug 15.